about
THERAPY OF ENDOCRINE DISEASE: Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysisAdipsic diabetes insipidus following pituitary surgery for a macroprolactinoma.Clinical insights into adipsic diabetes insipidus: a large case series.SFRP2 Is Associated with Increased Adiposity and VEGF Expression.Vancomycin administration: the impact of multidisciplinary interventionsCompliance with established guidelines for the radiological reporting of atypical femoral fracturesSecondary resistance to cabergoline therapy in a macroprolactinoma: a case report and literature review.Growth of a progesterone receptor-positive meningioma in a female patient with congenital adrenal hyperplasia.Hungry bone syndrome and normalisation of renal phosphorus threshold after total parathyroidectomy for tertiary hyperparathyroidism in X-linked hypophosphataemia: a case report.Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.The utility of 99mTc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidism.Central hypoadrenalism.Elevated PTH with normal serum calcium level: a structured approach.The incidence of anterior pituitary hormone deficiencies in patients with microprolactinoma and idiopathic hyperprolactinaemia.Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alström syndrome.The natural history of surgically treated but radiotherapy-naïve nonfunctioning pituitary adenomas.Symptoms of gonadal dysfunction are more predictive of hypopituitarism than nonspecific symptoms in screening for pituitary dysfunction following moderate or severe traumatic brain injury.Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol.Atypia of Undetermined Significance in Thyroid Fine Needle Aspirates: a 4-Year Audit of Thy3a Reporting.Therapeutic drug monitoring of vancomycin in patients receiving haemodialysis: time for a change.When would I use medical therapies for the treatment of primary hyperparathyroidism?Spironolactone interference in the immunoassay of androstenedione in a patient with a cortisol secreting adrenal adenoma.A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance.Acute glucocorticoid deficiency and diabetes insipidus are common after acute traumatic brain injury and predict mortality.Serum prolactin concentration at presentation of non-functioning pituitary macroadenomas.Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status.Epidural pneumatosis associated with spontaneous pneumomediastinum: a rare complication of diabetic ketoacidosis.Somnolence in adult craniopharyngioma patients is a common, heterogeneous condition that is potentially treatable.Developments in rare bone diseases and mineral disorders.RESPONSE LETTER.How to approach hypercalcaemia.Limited utility of tartrate-resistant acid phosphatase isoform 5b in assessing response to therapy in osteoporosis.DIABETIC KETOACIDOSIS IN PATIENTS WITH TYPE 2 DIABETES RECENTLY COMMENCED ON SGLT-2 INHIBITORS: AN ONGOING CONCERN.Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.Laboratory Trend in Vitamin D Status in Ireland: Dual Concerns about Low and High 25OHDEnsuring we involve seldom heard voices in supporting the Data Protection Act 2018 (Section 36(2)) (Health Research) Regulations 2018Congenital hypophosphataemia in adults: determinants of bone turnover markers and amelioration of renal phosphate wasting following total parathyroidectomyGetting to the heart of hypopituitarismManagement of Craniopharyngioma - Perspectives beyond Surgery and EndocrinologyComparison of polyethylene glycol vs sodium picosulphate vs sodium biphosphonate by efficacy in bowel cleansing and patients' tolerability: a randomised trial
P50
Q28068357-15423D63-C382-449C-BA82-E16DC7EAE805Q34526725-6CF4EB52-178B-4D61-B0ED-5A64EDB57B3BQ34610103-C5DC5C31-C15A-4487-A28C-79A52357BC61Q36148529-C7CB2E36-58A3-4F11-A369-8F05C53F950BQ36733457-842FA252-FB50-4C95-8103-C4EE9248D83BQ37177831-DE6F0FAD-8FC8-453D-9C68-895CCAF8CDE6Q37384810-7AE341E4-08F9-479E-946F-1038CE21DB4DQ37428555-D1E3A5F3-A62F-41FA-9873-1BC7C07906BCQ37623826-60312F53-5034-4183-8A8C-7CADF4115914Q37639062-982DDC25-E959-4EED-8F39-690D0F6113EBQ37809487-B2AFC613-3D3C-4A50-B1DC-D503A211713EQ38241566-9F5094D5-6D85-4832-B136-9234166AEAABQ38759343-AD296AAA-C6BC-48BA-966B-E102B7AE7D16Q38829397-A82525BF-3B75-4CE3-B166-D8117067B6BAQ39767055-E3E390E9-F7AA-4C5B-A11B-A8190275BFB1Q39993591-EC4210F5-2779-4B2D-A406-8318F79B1718Q40648123-75839CF5-4C1B-430A-9EB7-4D612F360758Q41464320-F1CA5C72-72F9-4960-94AB-A54375F12711Q42667575-44E79E2A-9BB5-4286-A616-E0A3369FECB0Q42835349-0A92EE94-412C-4952-AC2C-41E1C92A5683Q43662645-5FA94D9F-B4A6-49EA-9095-0C404F55FE88Q44066611-8CFE340A-322F-4D05-8FED-247E9AD5A3D6Q44758206-9E9D3C80-2184-471A-B3E5-1DA11FDF6053Q45849329-7E9E895F-E663-4E29-8D8D-7E605D12E192Q45978153-081F5ED2-7840-4832-BB95-A02F20510954Q46363385-8ECE43B9-24D5-403D-A913-7E018A2EBFA9Q48036497-21808F5B-0CAA-4EC5-97E0-678F0AA42870Q48305879-CD7E7608-2708-4935-9D71-C14EBE477F1EQ49413973-DC729FEE-1CC9-43F3-927F-B22B0F675FEFQ49714678-4BB65EAF-0C42-4F57-A503-B33B379FBF3FQ50913732-48D69628-4B7D-41B8-9BDE-9C5BA05747F0Q50936594-24A33170-1706-405A-8F10-A97E57A082D4Q51038310-64CC91C7-E687-4F80-9B13-D3C5A28254C8Q51386714-DF668002-E7D7-4F31-9257-0F67AD187AABQ57185156-B44323F3-53B0-4238-98A6-6F7129A31F60Q58999568-23B7A54D-84D9-4719-B78D-145C24EFAD6BQ60668167-5ED08EFE-82F7-4F1D-A708-CF183DD77533Q60668170-069F06C6-5CF4-4A1D-9D21-8D569AB72CA8Q60668175-6B2B3F42-1C99-4494-A026-BC905DBEB578Q60668177-38EE3C62-2EEC-40D2-A2F1-8326EA286502
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rachel K Crowley
@ast
Rachel K Crowley
@en
Rachel K Crowley
@es
Rachel K Crowley
@nl
Rachel K Crowley
@sl
type
label
Rachel K Crowley
@ast
Rachel K Crowley
@en
Rachel K Crowley
@es
Rachel K Crowley
@nl
Rachel K Crowley
@sl
altLabel
RK Crowley
@en
Rachel K Crowley
@en
prefLabel
Rachel K Crowley
@ast
Rachel K Crowley
@en
Rachel K Crowley
@es
Rachel K Crowley
@nl
Rachel K Crowley
@sl
P106
P21
P31
P496
0000-0003-1472-4117